Fundamentals

Valuation

Metric	Q1	Q3	Δ in %
EV/EBITDA	-78.34	66.03	-304.91
Graham Fair Price	13.28	0.58	0.51
PEG	27.56	-1.20	0.94
Price/Book	-11.32	1.58	1.79
Price/Cash Flow	288.53	174.82	-44.99
Prices/Earnings	-27.09	58.79	-80.63
Price/Sales	-54.30	8.52	18.64
Price/FCF	288.53	174.82	-44.99
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q3	Δ in %
Gross Profit Margin	136.80	0.25	0.11
Operating Margin	88.74	0.12	-0.07
ROA	19.09	< 0.005	< 0.005
ROE	< 0.005	< 0.005	21.62
ROIC	< 0.005	0.02	179.37
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q3	Δ in %
Debt QOQ	< 0.005	0.07	-93.79
Dividends QOQ	1.76	-1.00	-43.06
EBIT QOQ	0.84	0.17	-80.30
EPS QOQ	0.86	-0.49	-42.84
FCF QOQ	-26.01	-0.83	96.79
Revenue QOQ	0.03	-0.21	702.81
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	208.04	85.01	-59.14
Days Sales Outstanding (DSO)	124.20	62.39	-49.77
Inventory Turnover	0.43	1.06	144.72
Debt/Capitalization	0.04	0.14	203.87
Quick Ratio	0.58	1.00	71.58
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q3	Δ in %
Book Value	1.44	1.79	23.81
Cash	0.18	0.45	156.83
Capex	< 0.005	0.01	791.24
Free Cash Flow	-0.06	0.01	-76.56
Revenue	0.14	0.28	99.31
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q3	Δ in %
Current Ratio	1.17	1.28	10.17
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.87	-3.79	-51.90
Naive Interpretation	Member

06 - Financial Health · Weak

Rating